Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-057891
Filing Date
2021-11-10
Accepted
2021-11-09 21:18:47
Documents
5
Period of Report
2021-11-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea150323-6k_immuronlimited.htm 6-K 12586
2 US DOD NAVAL MEDICAL RESEARCH CENTER CLINICAL UPDATE ea150323ex99-1_immuron.htm EX-99.1 23279
3 GRAPHIC image_001.jpg GRAPHIC 2956
4 GRAPHIC ex99-1_001.jpg GRAPHIC 6091
5 GRAPHIC ex99-1_002.jpg GRAPHIC 1682
  Complete submission text file 0001213900-21-057891.txt   52079
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 211394108
SIC: 2834 Pharmaceutical Preparations